TruBridge (NASDAQ:TBRG - Get Free Report)'s stock had its "equal weight" rating reissued by equities research analysts at Stephens in a report issued on Thursday,Benzinga reports. They presently have a $28.00 price objective on the stock. Stephens' price target would suggest a potential upside of 15.61% from the company's previous close.
Separately, Cantor Fitzgerald boosted their price target on shares of TruBridge from $20.00 to $29.00 and gave the stock an "overweight" rating in a research note on Tuesday, March 11th.
View Our Latest Research Report on TBRG
TruBridge Trading Down 0.7 %
Shares of TBRG traded down $0.16 during trading on Thursday, reaching $24.22. 138,903 shares of the company traded hands, compared to its average volume of 130,648. The stock has a 50-day simple moving average of $27.44 and a 200-day simple moving average of $20.86. The stock has a market cap of $362.06 million, a PE ratio of -5.92, a price-to-earnings-growth ratio of 5.38 and a beta of 0.64. TruBridge has a twelve month low of $7.61 and a twelve month high of $32.00. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00.
Insider Transactions at TruBridge
In other news, CEO Christopher L. Fowler sold 5,100 shares of the business's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $27.02, for a total transaction of $137,802.00. Following the completion of the sale, the chief executive officer now owns 142,939 shares in the company, valued at approximately $3,862,211.78. The trade was a 3.45 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Pinetree Capital Ltd. bought 74,981 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was bought at an average cost of $27.61 per share, for a total transaction of $2,070,225.41. Following the completion of the transaction, the insider now directly owns 693,981 shares in the company, valued at approximately $19,160,815.41. The trade was a 12.11 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders bought 116,728 shares of company stock valued at $3,239,879. Insiders own 10.70% of the company's stock.
Hedge Funds Weigh In On TruBridge
Several hedge funds have recently made changes to their positions in TBRG. Tower Research Capital LLC TRC lifted its holdings in shares of TruBridge by 47.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company's stock valued at $43,000 after purchasing an additional 699 shares during the last quarter. Covestor Ltd lifted its stake in TruBridge by 20.5% in the fourth quarter. Covestor Ltd now owns 2,819 shares of the company's stock valued at $56,000 after buying an additional 479 shares during the last quarter. AlphaQuest LLC acquired a new stake in shares of TruBridge in the fourth quarter valued at approximately $66,000. FMR LLC acquired a new position in shares of TruBridge in the 3rd quarter valued at $85,000. Finally, EMC Capital Management boosted its stake in TruBridge by 2,704.0% during the 4th quarter. EMC Capital Management now owns 5,608 shares of the company's stock worth $111,000 after purchasing an additional 5,408 shares during the period. Hedge funds and other institutional investors own 88.64% of the company's stock.
About TruBridge
(
Get Free Report)
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
See Also
Before you consider TruBridge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TruBridge wasn't on the list.
While TruBridge currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.